Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65630 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
(Pyridin-2-ylmethylene)bis(4,1-phenylene) diacetate
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:361.3970031738281Methyl 3-(2-indol-3-yl-2-oxoacetylamino)thiophene-2-carboxylate, 98%
Molecular weight:328.33999633789063-(2,4-dimethylphenyl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one
CAS:Purity:98%Molecular weight:282.3599853515625rac-Ruxolitinib
CAS:Controlled Product<p>Applications rac-Ruxolitinib is the racemic analogue of Ruxolitinib (R702000). Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.<br>References Shilling, A.D. et al.: Drug Metab. Disp., 38, 2023 (2010); Mesa, R.A.: IDrugs, 13, 394 (2010); Campas-Moya, C.: Drugs Fut., 35, 457 (2010);<br></p>Formula:C17H18N6Color and Shape:NeatMolecular weight:306.36Ref: 10-F865697
1mgTo inquire10mgTo inquire25mgTo inquire50mgTo inquire100mgTo inquire250mgTo inquireBupivacaine
CAS:<p>Bupivacaine (AH-250) is a NMDA receptor inhibitor.Bupivacaine can block sodium, L-calcium, and potassium channels.Bupivacaine potently blocks SCN5A channels</p>Formula:C18H28N2OPurity:99.83%Color and Shape:SolidMolecular weight:288.43Deracoxib
CAS:Controlled Product<p>Applications Deracoxib is a non-steroidal anti-inflammatory drug (NSAID) of the coxib class. Deracoxin is a selective cyclooxygenase-2 (COX-2) inhibitor used in the treatment of osteoarthritis in dogs. At low doses, adminsitartion of Deracoxin showed no factors associated with gastrointestinal tract perforation.<br>References Lascelles, B.D.X. et al.: J. Am. Vet. Med. Assoc., 227, 1112 (2005); Anderson, G.D. et al.: Inflam. Res., 58, 109 (2009); Brainard, B.M. et al.: Am. J. Vet. Res., 68, 251 (2007);<br></p>Formula:C17H14F3N3O3SColor and Shape:Light BrownMolecular weight:397.37N-2 Trityl Olmesartan Medoxomil
CAS:<p>Impurity Olmesartan Medoxomil EP Impurity D<br>Applications Olmesartan medoxomil intermediate.<br>References Birkenhager, W., et al.: J. Hypertens, 17, 873 (1999), Whittaker, A., et al.: Br. J. Cardiol., 12, 125 (2005),<br></p>Formula:C48H44N6O6Color and Shape:White To Light YellowMolecular weight:800.90Ref: 10-F987646
1gTo inquire5gTo inquire5mg80.00€10mg102.00€25mg211.00€50mg362.00€100mgTo inquire250mgTo inquire1,3-Diphenyl-1 H -pyrazole-4-carboxylic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:264.28399658203125Tryptophol
CAS:Controlled Product<p>Applications Tryptophol is a metabolite formed in the liver after disulfiram treatment that induces sleep in humans. It is also a secondary product of alcoholic fermentation.<br>References Cornford, E.M., et al.: J Clin Invest, 63, 1241-1248 (1979)<br></p>Formula:C10H11NOColor and Shape:NeatMolecular weight:161.2Oxethazaine
CAS:<p>Oxethazaine (Oxetacaine), a topical anesthetic, is used to prevent acid-induced esophageal pain.</p>Formula:C28H41N3O3Purity:99.875% - 99.94%Color and Shape:Physical Description White Powder (Ntp 1992)Molecular weight:467.647-Hydroxy Granisetron-d3 Hydrochloride
CAS:Controlled Product<p>Applications 7-Hydroxy Granisetron-d3 Hydrochloride is a labelled Granisetron (G780000) metabolite.<br>References Bloomer, J., et al.: Brit. J. Clin. Pharmacol., 38, 557 (1994), Vernekar, S.,e t al.: J. Med. Chem., 53, 2324 (2010),<br></p>Formula:C182H3H21N4O2·ClHColor and Shape:NeatMolecular weight:367.892-[2-(pyridin-3-yl)-1H-indol-3-yl]ethan-1-amine hydrochloride
CAS:Purity:95.0%Molecular weight:273.760009765625[4-(5-pyridin-3-yl-1H-1,2,4-triazol-3-yl)phenyl]amine
CAS:Purity:95.0%Molecular weight:237.266006469726563-(4-Bromo-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-propionic acid
CAS:Formula:C8H8BrF3N2O2Purity:95.0%Color and Shape:SolidMolecular weight:301.063N-((4,6-dimethoxypyrimidin-2-yl)carbamoyl)-3-(trifluoromethyl)pyridine-2-sulfonamide
CAS:Purity:98%Color and Shape:SolidMolecular weight:407.32000736-Fluoro-3-[1-bis-[2-(methyl-6,7,8,9-tetrahydropyridol[1,2,a]pyrimidin-4-one-3-yl)ethyl]piperidinium]benzisoxazole Iodide
Controlled ProductFormula:C34H42FIN6O3Color and Shape:NeatMolecular weight:728.645-azetidin-3-yl-3-(3-thienyl)-1,2,4-oxadiazole hydrochloride
CAS:Purity:95.0%Molecular weight:243.71000671386723-acetyl-6-chloro-4-(4-methoxyphenyl)quinolin-2(1H)-one
CAS:Purity:95.0%Molecular weight:327.760009765625Raltegravir β-D-Glucuronide
CAS:<p>Applications A metabolite of Raltegravir.<br>References Bosma, P., et al.: J. Biol. Chem., 269, 17960 (1994), Richman, D., et al.: Nature, 410, 995 (2001), Williams, J., et al.: Drug Metab. Dispos., 32, 1201 (2004), Miners, J., et al.: Biochem. Pharmacol., 71, 1531 (2006),<br></p>Formula:C26H29FN6O11Color and Shape:NeatMolecular weight:620.544-ethoxy-N-(pyridin-3-ylmethyl)-1,3-benzothiazol-2-amine
CAS:Purity:95.0%Molecular weight:285.36999511718754-Hydroxy Omeprazole Preparation Kit
CAS:Controlled ProductFormula:C16H17N3O3SColor and Shape:Off White SolidMolecular weight:331.392-(2,3-Dimethylbenzoyl)-5-(1,3-dioxolan-2-yl)thiophene
CAS:Purity:97.0%Molecular weight:288.3599853515625Etoricoxib
CAS:Controlled ProductFormula:C18H15ClN2O2SColor and Shape:Off-WhiteMolecular weight:358.846-Allyl-8b-carboxyergoline
CAS:<p>Impurity Cabergoline EP Impurity A<br>Applications 6-Allyl-8β-carboxyergoline is a metabolite of cabergoline (C050000) which is a dopamine D2-receptor agonist.<br>References Brambilla, E., et al.: Eur. J. Med. Chem., 24, 421 (1989), Ferrari, C., et al.: J. Clin. Endocrinol. Metab., 68, 1201 (1989), Hutton, J.T., et al.: Neurology, 46, 1062 (1996)<br></p>Formula:C18H20N2O2Color and Shape:Light Beige SolidMolecular weight:296.3636N,N'-Bis(benzyloxycarbonyl)-1H-pyrazole-1-carboxamidine
CAS:Purity:99.0%Color and Shape:SolidMolecular weight:378.388000488281252-cyclopropyl-4-quinolinecarboxylic acid hydrate
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:231.251007080078123-Amino-5-(4-phenoxyphenyl)thiophene-2-carboxylic acid methyl ester
CAS:Color and Shape:SolidMolecular weight:325.3800048828125Ticagrelor Epimer
Controlled Product<p>Applications Ticagrelor Epimer is an epimer impurity of Ticagrelor (T437700). Ticagrelor (T437700), the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).<br>References Matetzky, S., et al.: Circulation, 109, 3171 (2004), Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007), Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007),<br></p>Formula:C23H28F2N6O4SColor and Shape:NeatMolecular weight:522.573-cyclopropyl-1-(4-fluorophenyl)-1H-pyrazol-5-amine
CAS:Purity:95+%Molecular weight:217.24699401855474-(6-Fluoropyridin-3-yl)-6-(2-hydroxy-2-methylpropoxy)pyrazolo[1,5-a]pyridine-3-carbonitrile
CAS:Purity:98%Molecular weight:326.33099365234375N-(3-Chloro-4-fluorophenyl)-N-(7-methoxy-6-nitroquinazolin-4-yl)acetamide
CAS:Purity:97.0%Molecular weight:390.760009765625(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(5-methylthiophen-2-yl)prop-2-en-1-one
CAS:Purity:95.0%Molecular weight:304.41000366210944-Morpholin-4-ylmethyl-1H-quinolin-2-one
CAS:Purity:97.0%Color and Shape:SolidMolecular weight:244.29400634765625
![2-(thiophen-2-yl)imidazo[1,2-b]pyridazine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF526637.webp&w=3840&q=75)
![2-[2-(pyridin-3-yl)-1H-indol-3-yl]ethan-1-amine hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF526101.webp&w=3840&q=75)
![[4-(5-pyridin-3-yl-1H-1,2,4-triazol-3-yl)phenyl]amine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF496128.webp&w=3840&q=75)
![6-Fluoro-3-[1-bis-[2-(methyl-6,7,8,9-tetrahydropyridol[1,2,a]pyrimidin-4-one-3-yl)ethyl]piperidini…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FF588410.webp&w=3840&q=75)
![4-(6-Fluoropyridin-3-yl)-6-(2-hydroxy-2-methylpropoxy)pyrazolo[1,5-a]pyridine-3-carbonitrile](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF604330.webp&w=3840&q=75)
![(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(5-methylthiophen-2-yl)prop-2-en-1-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF524244.webp&w=3840&q=75)
